Neuromodulation therapies and treatment-resistant depression

Medical Devices: Evidence and Research

Volumn 5, Issue 1, 2012, Pages 53-65

  Al Harbi, Khalid Saad ^a   Qureshi, Naseem Akhtar ^b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b General Administration for Research and Studies and Mental Health and Social Services   (Saudi Arabia)

Author keywords

Deep brain stimulation; Magnetic seizure therapy; Modified electro convulsive therapy; Modified electrotreatment resistant depression; Neuromodulation therapies; Transcranial direct current stimulation; Treatment resistant depression

Indexed keywords

COST EFFECTIVENESS; DATABASE SYSTEMS; ELECTROTHERAPEUTICS; OPTIMIZATION;

DEEP BRAIN STIMULATION; DIRECT CURRENT; MAGNETIC SEIZURE THERAPY; MODIFIED ELECTRO-CONVULSIVE THERAPY; MODIFIED ELECTROTREATMENT-RESISTANT DEPRESSION; NEUROMODULATION; TREATMENT-RESISTANT DEPRESSION;

SURGERY;

BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; CRANIAL ELECTRIC STIMULATION; ELECTROCONVULSIVE THERAPY; EPIDURAL CORTICAL STIMULATION; EVIDENCE BASED PRACTICE; FOCUSED ULTRASOUND; HUMAN; INFORMATION RETRIEVAL; LOW FIELD MAGNETIC STIMULATION; MAGNETIC SEIZURE THERAPY; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; MOOD DISORDER; NEAR INFRARED LIGHT THERAPY; NEUROMODULATION; NEUROMODULATION THERAPY; OPTOGENETIC STIMULATION; PUBLICATION; REVIEW; THERAPY; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; VAGUS NERVE STIMULATION;

EID: 84930478838     PISSN: None     EISSN: 11791470     Source Type: Journal    
DOI: 10.2147/MDER.S33198     Document Type: Review

References (113)

1. Preston JD. Introduction to Psychopharmacology: A Practical Clinician's Guide. 2010. Available from: http://www.continuingedcourses.net/active/courses/course015.php. Accessed May 24, 2012.
2. World Health Organization. Mental health: depression. Available from: http://www.who.int/mental_health/management/depression/definition/en. Accessed February 12, 2012.
3. Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67 Suppl 6:16-22.
4. Thase ME, Rush JA. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology. New York: Raven; 1995:1081-1097.
5. Ruhé HG, van Rooijen G, Spijker J, Peeters FP, Schene AH. Staging methods for treatment resistant depression. A systematic review. J Affect Disord. 2012;137(1-3):35-45.
6. Berlim MT, Fleck MP, Turecki G. Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Ann Med. 2008;40(2):149-159.
7. George MS. Brain stimulation treatments for depression: shifting the paradigm in treatment-resistant depression: assessing barriers to responses and applying adjunctive therapies for better patient results. www.vindicomeded.com/cmelc/psych_monograph1209.asp (Accessed on 12 May 2012).
8. Rosa MA, Lisanby SH. Somatic treatments for mood disorders. Neuropsychopharmacology. 2012;37:102-116.
9. Ward MP, Irazoqui PP. Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics. Front Neuroeng. 2010;3:7.
10. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64(6):461-467.
11. Mayberg HS, Brannan SK, Tekell JL, etal. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48(8):830-843.
12. Mayberg HS, Lozano AM, Voon V, etal. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651-660.
13. Greenberg BD, Malone DA, Friehs GM, etal. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006;31(11):2384-2393.
14. Malone DA Jr, Dougherty DD, Rezai AR, etal. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry. 2009;65(4):267-275.
15. Hälbig TD, Gruber D, Kopp UA, Schneider GH, Trottenberg T, Kupsch A. Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life. J Neurol Neurosurg Psychiatry. 2005;76(12):1713-1716.
16. Kosel M, Sturm V, Frick C, etal. Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. J Psychiatr Res. 2007;41(9):801-803.
17. Jimenez F, Velasco F, Salin-Pascual R, etal. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery. 2005;57:585-593.
18. Velasco F, Velasco M, Jiménez F, Velasco AL, Salin-Pascual R. Neurobiological background for performing surgical intervention in the inferior thalamic peduncle for treatment of major depression disorders. Neurosurgery. 2005;57:439-448.
19. Bewernick BH, Hurlemann R, Matusch A, etal. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry. 2009;67:110-116.
20. Rush AJ, George MS, Sackeim HA, etal. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry. 2000;47:276-286.
21. Nemeroff CB, Mayberg HS, Krahl SE, etal. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology. 2006;31(7):1345-1355.
22. George MS, Sackeim HA, Marangell LB, etal. Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am. 2000;23(4):757-783.
23. Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry. 2006;163(1):88-94.
24. Speer AM, Kimbrell TA, Wassermann EM, etal. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133-1141.
25. Avery DH, Holtzheimer PE 3rd, Fawaz W, etal. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006;59(2):187-194.
26. Frais AT. Electroconvulsive therapy: a theory for the mechanism of action. J ECT. 2010;26(1):60-61.
27. Kato N. Neurophysiological mechanisms of electroconvulsive therapy for depression. Neurosci Res. 2009;64(1):3-11.
28. Sánchez González R, Alcoverro O, Pagerols J, Rojo JE. Electrophysiological mechanisms of action of electroconvulsive therapy. Actas Esp Psiquiatr. 2009;37(6):343-351.
29. Bär KJ, Ebert A, Boettger MK, etal. Is successful electroconvulsive therapy related to stimulation of the vagal system? J Affect Disord. 2010;125(1-3):323-329.
30. Nordanskog P, Dahlstrand U, Larsson MR, Larsson EM, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT. 2010;26(1):62-67.
31. Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord. 2001;63:1-15.
32. Khalid N, Atkins M, Tredget J, Giles M, Champney-Smith K, Kirov G. The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study. J ECT. 2008;24(2):141-145.
33. Shelton RC, Osuntokun O, Heinloth AN, Corya SA. Therapeutic options for treatment-resistant depression. CNS Drugs. 2010;24(2): 131-161.
34. National Guideline Clearinghouse. Clinical Practice Guideline on Major Depression in Childhood and Adolescence. 2009. Available from: http://www.guideline.gov/content.aspx?id=25659. Accessed March 28, 2012.
35. Rasmussen KG, Mueller M, Rummans TA, etal. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). J Clin Psychiatry. 2009;70(2):232-237.
36. Perugi G, Medda P, Zanello S, Toni C, Cassano GB. Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimul. 2012;5(1):18-24.
37. Piccinni A, Del Debbio A, Medda P, etal. Plasma brain-derived neurotrophic factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharmacol. 2009;19(5): 349-355.
38. Okamoto T, Yoshimura R, Ikenouchi-Sugita A, etal. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1185-1190.
39. Ghaziuddin N, Dumas S, Hodges E. Use of continuation or maintenance electroconvulsive therapy in adolescents with severe treatment-resistant depression. J ECT. 2011;27(2):168-174.
40. Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT. 2010;26(3):223-227.
41. Baghai TC, Marcuse A, Brosch M, etal. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7(2): 82-90.
42. Fujita A, Nakaaki S, Segawa K, etal. Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression. J ECT. 2006;22: 107-112.
43. Crowley K, Pickle J, Dale R, Fattal O. A critical examination of bifrontal electroconvulsive therapy: clinical efficacy, cognitive side effects, and directions for future research. J ECT. 2008;24: 268-271.
44. Dumitriu D, Collins K, Alterman R, Mathew SJ. Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulation. Mt Sinai J Med. 2008;75:263-275.
45. George MS, Nahas Z, Borckardt JJ, etal. Brain stimulation for the treatment of psychiatric disorders. Curr Opin Psychiatry. 2007;20(3): 250-254.
46. Dougherty DD, Rauch SL. Somatic therapies for treatment-resistant depression: new neurotherapeutic interventions. Psychiatr Clin North Am. 2007;30(1):31-37.
47. Janicak PG, O'Reardon JP, Sampson SM, etal. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008;69:222-232.
48. Croarkin PE, Wall CA, McClintock SM, Kozel FA, Husain MM, Sampson SM. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. J ECT. 2010;26(4):323-329.
49. Fitzgerald PB, Hoy KE, Herring SE, etal. A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. J Affect Disord. Epub March 5, 2012.
50. Blumberger DM, Mulsant BH, Fitzgerald PB, etal. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World J Biol Psychiatry. Epub July 8, 2011.
51. Jhanwar VG, Bishnoi RJ, Jhanwar MR. Utility of repetitive transcranial stimulation as an augmenting treatment method in treatment-resistant depression. Indian J Psychol Med. 2011;33:92-96.
52. Dell'osso B, Camuri G, Castellano F, etal. Meta-review of metanalytic studies with repetitive transcranial magnetic stimulation (rTMS) for the treatment of major depression. Clin Pract Epidemiol Ment Health. 2011;7:167-177.
53. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008-2039.
54. Lefaucheur JP, André-Obadia N, Poulet E, etal. French guidelines on the use of repetitive transcranial magnetic stimulation (rTMS): safety and therapeutic indications. Neurophysiol Clin. 2011;41(5-6):221-295.
55. Martin JL, Barbanoj MJ, Schlaepfer TE, etal. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry. 2003;182:480-491.
56. Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci. 2005;30:83-90.
57. Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39:65-75.
58. Gross M, Nakamura L, Pascual-Leone A, etal. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs the earlier rTMS studies. Acta Psychiatr Scand. 2007;116:165-173.
59. Lam RW, Chan P, Wilkins-Ho M, etal. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry. 2008;53:621-631.
60. Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry. 2006;67:1870-1876.
61. Moreines JL, McClintock SM, Holtzheimer PE. Neuropsychological effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul. 2011;4(1):17-27.
62. Nahas Z, Burns C, Foust MJ, Short B, Herbsman T, George MS. Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next? Curr Psychiatry Rep. 2006;8(6):445-451.
63. O'Reardon JP, Cristancho P, Peshek AD. Vagus nerve stimulation (VNS) and treatment of depression: to the brainstem and beyond. Psychiatry. 2006;3(5):54-63.
64. Goodman WK, Insel TR. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry. 2009;65(4):263-266.
65. Carpenter LL, Moreno FA, Kling MA, etal. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry. 2004;56:418-426.
66. Marangell LB, Rush AJ, George MS, etal. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002;51(4):280-287.
67. Bajbouj M, Merkl A, Schlaepfer TE, etal. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol. 2010;30(3):273-281.
68. Cristancho P, Cristancho MA, Baltuch GH, Thase ME, O'Reardon JP. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year. J Clin Psychiatry. 2011;72(10): 1376-1382.
69. Warnell RL, Elahi N. Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: a case study and cost analysis. J ECT. 2007;23(2):114-119.
70. Mohr P, Rodriguez M, Slavíčková A, Hanka J. The application of vagus nerve stimulation and deep brain stimulation in depression. Neuropsychobiology. 2011;64(3):170-180.
71. Sackeim HA, Rush AJ, George MS, etal. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713-728.
72. Boggio PS, Rigonatti SP, Ribeiro RB, etal. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol. 2008;11(2):249-254.
73. Loo CK, Sachdev P, Martin D, etal. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol. 2010;13(1):61-69.
74. Palm U, Schiller C, Fintescu Z, etal. Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study. Brain Stimul. Epub September 7, 2011.
75. Tierney TS, Sankar T, Lozano AM. Deep brain stimulation emerging indications. Prog Brain Res. 2011;194:83-95.
76. Hardesty DE, Sackeim HA. Deep brain stimulation in movement and psychiatric disorders. Biol Psychiatry. 2007;61:831-835.
77. Kopell BH, Greenberg BD. Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry. Neurosci Biobehav Rev. 2008;32(3):408-422.
78. Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest. 2009;119(4):717-725.
79. Tye SJ, Frye MA, Lee KH. Disrupting disordered neurocircuitry: treating refractory psychiatric illness with neuromodulation. Mayo Clin Proc. 2009;84(6):522-532.
80. Schlaepfer TE, Bewernick B, Kayser S, Lenz D. Modulating affect, cognition, and behavior-prospects of deep brain stimulation for treatment-resistant psychiatric disorders. Front Integr Neurosci. 2011;5:29.
81. Lujan JL, Chaturvedi A, Malone DA, Rezai AR, Machado AG, McIntyre CC. Axonal pathways linked to therapeutic and nontherapeutic outcomes during psychiatric deep brain stimulation. Hum Brain Mapp. 2012;33(4):958-968.
82. Bewernick BH, Hurlemann R, Matusch A, etal. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry. 2010;67(2):110-116.
83. Lozano AM, Giacobbe P, Hamani C, etal. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg. 2012;116(2):315-322.
84. Klein E, Kreinin I, Chistyakov A, etal. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry. 1999;56:315-320.
85. Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res. 2011;45(5):569-576.
86. Blomstedt P, Sjoberg RL, Hansson M, Bodlund O, Hariz MI. Deep brain stimulation in the treatment of depression. Acta Psychiatr Scand. 2011;123:4-11.
87. Holtzheimer PE, Kelley ME, Gross RE, etal. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69(2):150-158.
88. Kennedy SH, Giacobbe P, Rizvi SJ, etal. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry. 2011;168(5):502-510.
89. Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S, Kennedy SH. Neurostimulation therapies for treatment resistant depression: a focus on vagus nerve stimulation and deep brain stimulation. Int Rev 2011;23(5):424-436.
90. Berney A, Vingerhoets F, Perrin A, etal. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology. 2002;59:1427-1429.
91. Binder DK, Rau G, Starr PA. Hemorrhagic complications of microelectrode-guided deep brain stimulation. Stereotact Funct Neurosurg. 2003;80:28-31.
92. Kirov G, Ebmeier KP, Scott AIF, etal. Quick recovery of orientation after 100Hz magnetic seizure therapy (MST) for major depressive disorder. Br J Psychiatry. 2008;193(2):152-155.
93. Zyss T, Zieba A, Hese RT, etal. Magnetic seizure therapy (MST)-a safer method for evoking seizure activity than current therapy with a confirmed antidepressant efficacy. Neuro Endocrinol Lett. 2010;31(4):425-437.
94. Moscrip TD, Terrace HS, Sackeim HA, Lisanby SH. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol. 2006;9(1):1-11.
95. Cycowicz YM, Luber B, Spellman T, Lisanby SH. Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes. J ECT. 2009;25(3):157-164.
96. Dwork AJ, Christensen JR, Larsen KB, etal. Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy. Neuroscience. 2009;164(4):1557-1564.
97. Rowny SB, Cycowicz YM, McClintock SM, Truesdale MD, Luber B, Lisanby SH. Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model. Neuroimage. 2009;47(3):1086-1091.
98. Carpenter LL. Neurostimulation in resistant depression. J Psychopharmacol. 2006;20(Suppl 3):35-40.
99. Kennedy SH, Milev R, Giacobbe P, etal. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 2009;117 Suppl 1:S44-S53.
100. Ward HE, Hwynn N, Okun MS. Update on deep brain stimulation for neuropsychiatric disorders. Neurobiol Dis. 2010;38(3):346-353.
101. Bystritsky A, Kerwin L, Feusner J. A pilot study of cranial electrotherapy stimulation for generalized anxiety disorder. J Clin Psychiatry. 2008;69:412-417.
102. Klawansky S, Yeung A, Berkey C, Shah N, Phan H, Chalmers TC. Meta-analysis of randomized controlled trials of cranial electrostimulation. Efficacy in treating selected psychological and physiological conditions. J Nerv Ment Dis. 1995;183:478-484.
103. Stagg CJ, Nitsche MA. Physiological basis of transcranial direct current stimulation. Neuroscientist. 2011;17:37-53.
104. Nahas Z, Anderson BS, Borckardt J, etal. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010;67:101-109.
105. Kirsch DL, Smith RB. The use of cranial electrotherapy stimulation in the management of chronic pain: a review. Neuro Rehabilitation. 2000;14:85-94.
106. Tyler WJ, Tufail Y, Finsterwald M, Tauchmann ML, Olson EJ, Majestic C. Remote excitation of neuronal circuits using low-intensity, low-frequency ultrasound. PLoS One. 2008;3:e3511.
107. Volkow ND, Tomasi D, Wang GJ, etal. Effects of low-field magnetic stimulation on brain glucose metabolism. Neuroimage. 2010;51:623-628.
108. Katz EJ, Ilev IK, Krauthamer V, Kim do H, Weinreich D. Excitation of primary afferent neurons by near-infrared light in vitro. Neuroreport. 2010;21:662-666.
109. Mathew M, Amat-Roldan I, Andres R, etal. Signalling effect of NIR pulsed lasers on axonal growth. J Neurosci Methods. 2010;186:196-201.
110. Zhang F, Aravanis AM, Adamantidis A, de Lecea L, Deisseroth K. Circuit-breakers: optical technologies for probing neural signals and systems. Nat Rev Neurosci. 2007;8:577-581.
111. Covington HE 3rd, Lobo MK, Maze I, etal. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci. 2010;30:16082-16090.
112. Gaynes BN, Lux L, Lloyd S, etal. Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults. 2011. Available from: http://www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed April 3, 2012.
113. Brunoni AR, Teng CT, Correa C, etal. Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting. Arq Neuropsiquiatr. 2010;68(3):433-451.